Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model

HSPCs were corrected using SpCas9NG-ABE-eVLPs without off-target effects being detected. Even in settings of low editing, transplantation of BE-corrected HSPCs into αCD117-ADC-conditioned mice led to efficient immune cell production in peripheral blood with normal B cell progenitors in the bone marrow. Combining αCD117-ADC conditioning with transplantation of HSPCs that were base edited using eVLPs successfully reversed the SCID phenotype in mice, showcasing a significant advancement in reducing treatment-related toxicities while enabling disease correction.

Authors

Institutions

Publication Details

Journal
Molecular Therapy
Published
2026-04-01
DOI
https://doi.org/10.1016/j.ymthe.2026.04.010
Primary Topic
T-cell and B-cell Immunology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model

Hana Willner, Carsten T. Charlesworth, Agnieszka Czechowicz, Jack A. Queenan et al.
Molecular Therapy
T-cell and B-cell Immunology
article

Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model

Hana Willner, Carsten T. Charlesworth, Agnieszka Czechowicz, Jack A. Queenan, Jessie R. Davis, Leah Swartzrock, Morgane Denis, Carla Dib, Ross C. Wilson, Rina J. Mepani, Madalena Castro, Katie Ho, Hiromitsu Nakauchi, David R. Liu
article en

Abstract

HSPCs were corrected using SpCas9NG-ABE-eVLPs without off-target effects being detected. Even in settings of low editing, transplantation of BE-corrected HSPCs into αCD117-ADC-conditioned mice led to efficient immune cell production in peripheral blood with normal B cell progenitors in the bone marrow. Combining αCD117-ADC conditioning with transplantation of HSPCs that were base edited using eVLPs successfully reversed the SCID phenotype in mice, showcasing a significant advancement in reducing treatment-related toxicities while enabling disease correction.

Molecular Therapy
QB3 (US), Broad Institute (US), California Institute for Regenerative Medicine (US), Institute for Stem Cell Biology and Regenerative Medicine (IN), Innovative Genomics Institute (US), University of California, Berkeley (US), Stanford University (US)
Howard Hughes Medical Institute, American Society for Transplantation and Cellular Therapy, National Institutes of Health, School of Medicine, Stanford University
Life in Land
Openalex Percentile: Top 28%
T-cell and B-cell Immunology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Restoration of the immune system with base editing and non-genotoxic conditioning in a Rag2 point-mutant mouse model — Hana Willner, Carsten T. Charlesworth, et al. · Molecular Therapy (2026) | TGRS Research Map | TGRS